Influence of Genetic Risk Factors on Coronary Heart Disease Occurrence in Afro-Caribbeans

Canadian Journal of Cardiology

Volumn 32, Issue 8, 2016, Pages 978-985

  Larifla, Laurent ^a,b,c   Beaney, Katherine E ^b   Foucan, Lydia ^a   Bangou, Jacqueline ^a   Michel, Carl T ^c   Martino, Jean ^c   Velayoudom Cephise, Fritz Line ^a   Cooper, Jackie A ^b   Humphries, Steve E ^b  

^a UNIVERSITÉ DES ANTILLES   (France)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c University of the French West Indies   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN CARIBBEAN; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DIABETES MELLITUS; ETHNIC GROUP; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC RISK; GENETIC RISK SCORE; GENETIC SUSCEPTIBILITY; GENETIC VARIATION; GENOTYPE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; RISK ASSESSMENT; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; BLACK PERSON; CASE CONTROL STUDY; CORONARY ARTERY DISEASE; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; GUADELOUPE;

AFRICAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CORONARY DISEASE; DIABETES MELLITUS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GUADELOUPE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK ASSESSMENT; SMOKING;

EID: 84959933661     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2016.01.004     Document Type: Article

References (28)

1. 1 World Health Organization. The 10 leading causes of death in the world, 2000 and 2012. Available at: http://www.who.int/mediacentre/factsheets/fs310/en/. Accessed December 30, 2015.
2. 2 Yusuf, S., Hawken, S., Ounpuu, S., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364 (2004), 937–952.
3. 3 Artaud-Wild, S.M., Connor, S.L., Sexton, G., Connor, W.E., Differences in coronary mortality can be explained by differences in cholesterol and saturated fat intakes in 40 countries but not in France and Finland. A paradox. Circulation 88 (1993), 2771–2779.
4. 4 Ecological analysis of the association between mortality and major risk factors of cardiovascular disease. The World Health Organization MONICA Project. Int J Epidemiol 23 (1994), 505–516.
5. 5 Foucan, L., Bangou-Bredent, J., Ekouevi, D.K., et al. Hypertension and combinations of cardiovascular risk factors. An epidemiologic case-control study in an adult population in Guadeloupe (FWI). Eur J Epidemiol 17 (2001), 1089–1095.
6. 6 Inamo, J., Daigre, J.L., Boissin, J.L., et al. High blood pressure and obesity: disparities among four French overseas territories. J Hypertens 29 (2011), 1494–1501.
7. 7 Guadeloupe Ordlsd. Available at: http://www.orsag.fr/maladies-cardio-vasculaires/63-cardiopathies-ischemiques-guadeloupe.html2012. Accessed April 30, 2015.
8. 8 Sans, S., Kesteloot, H., Kromhout, D., The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe. Eur Heart J 18 (1997), 1231–1248.
9. 9 Chaturvedi, N., Ethnic differences in cardiovascular disease. Heart 89 (2003), 681–686.
10. 10 Wild, S., McKeigue, P., Cross sectional analysis of mortality by country of birth in England and Wales, 1970-92. BMJ 314 (1997), 705–710.
11. 11 Humphries, S.E., Drenos, F., zen-Dror, G., Talmud, P.J., Coronary heart disease risk prediction in the era of genome-wide association studies: current status and what the future holds. Circulation 121 (2010), 2235–2248.
12. 12 Miller, G.J., Bauer, K.A., Barzegar, S., et al. The effects of quality and timing of venepuncture on markers of blood coagulation in healthy middle-aged men. Thromb Haemost 73 (1995), 82–86.
13. 13 Casas, J.P., Cooper, J., Miller, G.J., Hingorani, A.D., Humphries, S.E., Investigating the genetic determinants of cardiovascular disease using candidate genes and meta-analysis of association studies. Ann Hum Genet 70 (2006), 145–169.
14. 14 CARDIoGRAMplusC4D Consortium, Deloukas, P., Kanoni, S., Willenborg, C., et al. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet 45 (2013), 25–33.
15. 15 Beaney, K.E., Cooper, J.A., Ullah Shahid, S., et al. Clinical utility of a coronary heart disease risk prediction gene score in UK healthy middle aged men and in the Pakistani population. PLoS One, 10, 2015, e0130754.
16. 16 Schunkert, H., König, I.R., Kathiresan, S., et al. Large-scale association analyses identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 43 (2011), 333–338.
17. 17 Bennet, A.M., Di Angelantonio, E., Ye, Z., et al. Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA 298 (2007), 1300–1311.
18. 18 Benn, M., Nordestgaard, B.G., Grande, P., Schnohr, P., Tybjaerg-Hansen, A., PCSK9 R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease: 3 independent studies and meta-analyses. J Am Coll Cardiol 55 (2010), 2833–2842.
19. 19 Palmen, J., Smith, A.J., Dorfmeister, B., et al. The functional interaction on in vitro gene expression of APOA5 SNPs, defining haplotype APOA52, and their paradoxical association with plasma triglyceride but not plasma apoAV levels. Biochimet Biophys Acta 1782 (2008), 447–452.
20. 20 Balarajan, R., Ethnic differences in mortality from ischaemic heart disease and cerebrovascular disease in England and Wales. BMJ 302 (1991), 560–564.
21. 21 Ethnicity and cardiovascular disease. The incidence of myocardial infarction in white, South Asian, and Afro-Caribbean patients with type 2 diabetes (U.K. Prospective Diabetes Study 32). Diabetes Care 21 (1998), 1271–1277.
22. 22 Forrest, R.D., Jackson, C.A., Yudkin, J.S., Glucose intolerance and hypertension in north London: the Islington Diabetes Survey. Diabet Med 3 (1986), 338–342.
23. 23 Chaturvedi, N., McKeigue, P.M., Marmot, M.G., Relationship of glucose intolerance to coronary risk in Afro-Caribbeans compared with Europeans. Diabetologia 37 (1994), 765–772.
24. 24 Marenberg, M.E., Risch, N., Berkman, L.F., Floderus, B., de Faire, U., Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 330 (1994), 1041–1046.
25. 25 Ripatti, S., Tikkanen, E., Orho-Melander, M., et al. A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses. Lancet 376 (2010), 1393–1400.
26. 26 Gillum, R.F., The epidemiology of cardiovascular disease in black Americans. N Engl J Med 335 (1996), 1597–1599.
27. 27 Lettre, G., Palmer, C.D., Young, T., et al. Genome-wide association study of coronary heart disease and its risk factors in 8,090 African Americans: the NHLBI CARe Project. PLoS Genet, 7, 2011, e1001300.
28. 28 Franceschini, N., Hu, Y., Reiner, A.P., et al. Prospective Associations of coronary heart disease loci in African Americans using the MetaboChip: The PAGE study. PloS One, 9, 2014, e113203.